|  |
 |
 |
 |
 |
| St. Petersburg Times Covers Clinical Trial Outsourcing to Indiaby Osagie K. Obasogie, Biopolitical TimesDecember 31st, 2008When we think of Pulitzer prize winning newspaper series, we often think of the New York Times or The Washington Post. But a new special report in the St. Petersburg Times on clinical trials in the developing world should give the big boys a run for their money next year. |
| Gene Doping Conference Makes Headlinesby Marcy Darnovsky, Biopolitical TimesDecember 24th, 2008A few advocates of gene doping by athletes regularly make the news, as they did at a conference last week. |
| Nature Makes Newsby Pete Shanks, Biopolitical TimesDecember 11th, 2008Nature has published a Commentary that advocates the use of "cognitive-enhancing drugs." |
| This Week in the Newsby Jesse Reynolds, Biopolitical TimesDecember 1st, 2008A weekly roundup of news stories that have not been covered at Biopolitical Times. |
| Reproductive health journal examines new technologiesby Marcy Darnovsky, Biopolitical TimesNovember 19th, 2008"Those working within the progressive advocacy landscape are increasingly challenged to develop a nuanced understanding of the benefits and risks of reproductive genetics." |
| Last Second Shotby Osagie Obasogie, Biopolitical TimesNovember 17th, 2008ESPN recently ran a web feature story and televised segment (see below) on NBA All- Star forward Carlos Boozer and his son’s struggle with sickle cell anemia. |
| Leftover embryo quandariesby Marcy Darnovsky, Biopolitical TimesOctober 7th, 2008Donating unused embryos, and minimizing conflicts of interest between fertility doctors and stem cell researchers.
|
| The spitterati and trickle-down genomicsby Marcy Darnovsky, Biopolitical TimesSeptember 17th, 200823andMe's use of celebrities and glitzy parties to promote its direct-to-consumer DNA tests has deflected attention from the concerns and criticisms of physicians, bioethicists, and regulators.
|
|
|
 |
 |
 |
 |
| |
|
Highlighted Topics
